Welcome to the Centre for Therapeutic Target Validation

For biomedical researchers who need to identify a biological target for a new therapy, the Centre for Therapeutic Target Validation (CTTV) is a public-private initiative to generate evidence on the validity of therapeutic targets based on genome-scale experiments and analysis. The CTTV is working to create an R&D framework that applies to a wide range of human diseases, and is committed to sharing its data openly with the scientific community.


Thursday, 27 March, 2014
A pioneering public-private research initiative between GSK, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute is to harness the power of ‘big data’ and genome sequencing to improve the success rate for discovering new medicines. The new Centre for Therapeutic Target Validation will share its data openly in the interests of accelerating drug discovery.


image press@targetvalidation.org
image +44 (0)1223 494 665